DecisionRx Partners with MotivHealth to Deliver Medication Therapy Optimization to Health Plan Members
Medication Therapy Optimization (MTO) is a precision medicine practice that uses clinical pharmacists, pharmacogenomics, and a sophisticated data-science toolset to reduce the human and financial costs of trial-and-error prescribing
“MotivHealth was founded to break the mold in the insurance market, and DecisionRx is doing the same when it comes to personalizing the approach to medication therapy,” said MotivHealth CEO
Studies show that approximately 40% of prescriptions either don’t work or introduce new medical problems, and these medication failures account for at least 16% of all healthcare costs. Through its data-driven MTO platform, clinically-trained DecisionRx pharmacists equip providers with information and specific recommendations that allow them to more effectively customize medication regimens for each patient.
“We are excited by the opportunity to impact the lives of MotivHealth’s members enrolled in our solution,” said DecisionRx President and Co-Founder
About MotivHealth
MotivHealth is revolutionizing the way people engage with health insurance by focusing on HSA-based insurance plans that produce lower premiums, better benefits, and improved wellness of its members. Motiv has been successfully lowering the costs of healthcare for hundreds of companies since 2015, with a mission to help employers build simple and affordable solutions that empower members to get the most out of their benefits. As a result, Motiv clients have enjoyed annual premium increases of <4% for the last several years. MotivHealth is headquartered in
About DecisionRx
DecisionRx is a technology-enabled healthcare services company, improving patient outcomes and reducing healthcare costs by helping providers optimize prescribing decisions for their patients. DecisionRx clinical pharmacists work on patients’ behalf to mitigate medication failure by making personalized medication recommendations to prescribers, informed by the latest clinical and data-science, and delivered in a value-based care model. Medication failure accounts for at least 16% of total healthcare spending, and medication therapy optimization has been shown to reduce the total annual cost of care by over
View source version on businesswire.com: https://www.businesswire.com/news/home/20241010748447/en/
Media
ICR Westwicke
646-277-1252
Alexis.Feinberg@westwicke.com
Source: DecisionRx


Gold Sales Explode at Costco as Investors Buy 3 Dividend Gold Stocks Hand-Over-Fist
Pete Galla Joins Alliant Insurance Services as Executive Vice President, Alliant M&A
Advisor News
- What to discuss during the first retirement planning meeting
- Inflation, competing priorities and uncertainty erode retirement security
- As health premiums rise, 1 in 8 workers cut retirement savings
- CT governor’s candidates claims: What’s true, and what’s misleading
- Retaining clients by giving them a memorable experience
More Advisor NewsAnnuity News
- National Life Group expands annuity portfolio
- AM Best to Join Life/Annuity Insurance-Focused Panel Discussion at Capitol Forum Event
- USAA Earns No. 1 Ranking in JD Power Individual Annuity Study for the Third Consecutive Year
- How flexible annuities fit today’s retirement portfolios
- Foresters Financial appoints Tom Ross as chief distribution officer for U.S. annuity sales
More Annuity NewsHealth/Employee Benefits News
- CONSUMER ADVISORY: OPEN ENROLLMENT STARTS NOV. 1: COMPARE OPTIONS AND FIND OUT HOW TO SAVE
- GOVERNOR SPANBERGER CELEBRATES COURT RULING PROTECTING HEALTHCARE COVERAGE FOR VIRGINIANS WITH SERIOUS ILLNESSES
- Kenai renews employee health coverage despite $792K jump in costs
- Healthcare navigator: More people are dropping insurance or choosing higher-deductible plans
- UnitedHealth Group Incorporated Trademark Application for “HPN” Filed: UnitedHealth Group Incorporated
More Health/Employee Benefits NewsLife Insurance News